CBPD-409
CBPD-409 is an orally active PROTAC degrader for CBP/p300, with DC50 of 0.2–0.4 nM. CBPD-409 exhibits antiproliferative effects in AR+ prostate cancer cell lines VCaP, LNCaP and 22Rv1, with IC50s of 1.2–2.0 nM. CBPD-409 exhibits antitumor efficacy (Red: CBP inhibitor GNE049 ; Blue: CRBN/cullin 4A Thalidomide (HY-14658) ; Black: Linker).
Product Specifications
CAS Number
3037549-86-0
UNSPSC
12352005
Target
Histone Acetyltransferase; PROTACs
Type
Reference compound
Related Pathways
Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cbpd-409.html
Purity
99.38
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1C2C(NC(CC2)=O)=O)C3=CC(N4CCN(C[C@@H]5CC[C@@H](N6C7=C(CN(C(C)=O)CC7)C(N8C9=C(CCC8)C=C(C(C(F)F)=C9)C%10=CN(C)N=C%10)=N6)CC5)CC4)=CC=C3C1=O
Molecular Formula
C46H52F2N10O5
Molecular Weight
862.97
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human Thrombopoietin (THPO) (Active)
Recombinant Human Thrombopoietin (THPO) (Active)
Recombinant Human Thrombopoietin (THPO) (Active)
Tert-Butyl 3- (bromomethyl) pyrrolidine-1-carboxylate ≥95% (GC)
Tert-Butyl 3- (bromomethyl) pyrrolidine-1-carboxylate ≥95% (GC)